Search Results for: Takeda
Licensing Rare Disease
Takeda Collaborates with Immusoft to Advance Treatments in Rare Metabolic Diseases
2022-01-14
Funding RNA Editing
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
M&A SanofiBispecific AntibodyT-cell Activation
Sanofi Bets $1 Billion on Preclinical Next-gen Immunotherapies
2021-12-22
China Peptide-drug Conjugates
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
Deals Parkinson’s Disease
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Asia-Pacific AAV Gene Therapy
Astellas Taps Dyno in $1.6+ Billion Deal to Develop AAV Gene Therapies
2021-12-02
Trials & Approvals Organ Transplant
Takeda’s Livtencity Bags FDA Approval for the Treatment of Post-Transplant Infection
2021-11-24
Trials & Approvals CAR T-cell Therapy
Considering Manufacturing and Commercial Advantages, Poseida Makes Strategic Shift Towards Allogeneic CAR-T Products
2021-11-10
Funding CAR T-cell Therapy
Blackstone Chips in $250 Million to Aid Autolus’ CAR-T Therapy
2021-11-09
Policy Rare Disease
Big Pharma and Non-Profits Join NIH, FDA in New Rare Diseases Drive
2021-10-28
M&A Cell Therapy
Takeda Snags UK-Based Cell Therapy Collaborator to Boost Immuno-Oncology Portfolio
2021-10-27
Funding Cell Therapy
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
Trials & Approvals Gene Therapy
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Funding Small Molecule Drug
ShouTi Raises $100M in Series B to “Replace Biologic Injections with Pills”
2021-10-21
Licensing RESILIENCE
Resilience, Harvard University Ink 5-Year Strategic R&D Alliance Leveraging Biomedical Innovation for a Resilient Tomorrow
2021-10-16
1 2 3 4 5 6 … 10
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top